Healius in cost-cutting mode down to the stationary measures
After a bull run during the pandemic when the pathology giant conducted 40,000 tests each working day, a staff memo says Healius is now cutting costs.
Stay updated with breaking news from Sustainable Improvement Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
After a bull run during the pandemic when the pathology giant conducted 40,000 tests each working day, a staff memo says Healius is now cutting costs.
Diagnostic and imaging healthcare corporation Healius [ASX:HLS] has acknowledged that declining COVID cases have resulted in sinking revenue year-on-year in its latest trading update.
Weekly update on stockbroker recommendation, target price, and earnings forecast changes
Recovery in the core business remains important in the near-term for Healius, as benefits from covid testing look likely to soften in the remainder of the year, but longer-term digitisation remains a focus for the company
4.43PM â Feb 24, 2021 Harmoney, MoneyMe lift personal loan originations in bank tech battle Loan originations are on the rise at two new, tech-driven personal lending brands, Harmoney and MoneyMe, which presented plans to beat the major banks at finding customers and assessing their risk but failed to convince the market. Harmoney and MoneyMe have both developed machine learning tools using broad data sets to assess customers; Harmoney said a new model using data from 53,000 Australian loan applicants had resulted in its âLibraâ system doubling originations in the middle two we...